.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Fish and Richardson
Deloitte
UBS
Covington
Fuji
US Army
Daiichi Sankyo
Chinese Patent Office
Harvard Business School

Generated: September 26, 2017

DrugPatentWatch Database Preview

Novast Labs Company Profile

« Back to Dashboard

What is the competitive landscape for NOVAST LABS, and what generic and branded alternatives to NOVAST LABS drugs are available?

NOVAST LABS has twenty-six approved drugs.

There are three tentative approvals on NOVAST LABS drugs.

Summary for Applicant: Novast Labs

Patents:0
Tradenames:25
Ingredients:12
NDAs:26
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novast Labs Ltd
MELAMISA
drospirenone; ethinyl estradiol
TABLET;ORAL202016-001Jan 26, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
PHILITH
ethinyl estradiol; norethindrone
TABLET;ORAL-28090947-001Dec 22, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
ACETAZOLAMIDE
acetazolamide
CAPSULE, EXTENDED RELEASE;ORAL203434-001Sep 30, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
LARIN 1.5/30
ethinyl estradiol; norethindrone acetate
TABLET;ORAL-21202996-001Mar 20, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
MONO-LINYAH
ethinyl estradiol; norgestimate
TABLET;ORAL-28090523-001May 23, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
YAELA
drospirenone; ethinyl estradiol
TABLET;ORAL-28202015-001Nov 19, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
INDOMETHACIN
indomethacin
CAPSULE, EXTENDED RELEASE;ORAL204853-001May 8, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs
NORETHINDRONE
norethindrone
TABLET;ORAL-28200961-001Sep 13, 2013AB2RXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
LARIN FE 1.5/30
ethinyl estradiol; norethindrone acetate
TABLET;ORAL-28091453-001Aug 23, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
LARIN 1/20
ethinyl estradiol; norethindrone acetate
TABLET;ORAL-21202995-001Dec 4, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Boehringer Ingelheim
Argus Health
Covington
Chinese Patent Office
Novartis
Federal Trade Commission
Citi
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot